1. Alvan G, Von Bahre C, Seideman P, Sjöqvist F (1982) High plasma concentration of β-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet I:333
2. Balant L, Mc Ainsh J (1980) Use of metabolite data in the evaluation of pharmacokinetics and drug action. In: Jenner P, Testa P (eds) Concepts in drug metabolism. Marcel Dekker, New York, pp 311–371
3. Baldessarini R (1980) Drugs and the treatment of psychiatric disorders. In: Goodman Gilman A, Goodman L, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Mcmillan, New York, pp 391–447
4. Dayer P, Courvoisier F, Balant L, Fabre J (1982a) Beta-blockers and drug oxidation status. Lancet I:509
5. Dayer P, Balant L, Courvoisier F, Küpfer A, Kubli A, Gorgia A, Fabre J (1982b) The genetic control of bufuralol in man. Eur J Drug Metab Pharmacokin 7:33–77